NEW YORK, Jan 4 – Third Wave Technologies said Thursday it had licensed its Invader genotyping system to Fairview University Medical Center in Minneapolis for a genotyping study to be sponsored by the NIH. 

Terms of the deal were not disclosed, although Third Wave generally opts for deals that give the company rights to discoveries made using its technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.